COVID-19 Therapeutics

Suitecase

COVID-19 Therapeutics in Virginia 

This webpage is for health care professionals and focuses on common antiviral treatments that can be used in the outpatient setting. 

COVID-19 cases can result in serious illness, hospitalizations and deaths. In brief, COVID-19 therapeutics are indicated for symptomatic patients with mild to moderate COVID-19 who are at increased risk for progression to severe disease. Drug therapy needs to be started quickly after the onset of symptoms and use of these medications is considered a recommended practice for patients. COVID-19 antiviral therapy has been shown to prevent worsening illness, and COVID-19-related hospitalizations and deaths. More recent data has shown that the earlier antiviral therapy is started, the more effective it is. 
 

Date Last Updated: February 27, 2024

Opens pdf to download

Opens in a new window

External link will open in a new window.  Click link to exit Virginia Department of Health Website.